Lamivudine Structural Formula (166abd26 675e 4832 9d18 0567f2a9d4e4 01)
Epivir
Product Images NDC 21695-367
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Epivir (NDC 21695-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Systemic Clearance (l/hr•kg) Of Lamivudine In Relation To Age (166abd26 675e 4832 9d18 0567f2a9d4e4 02)
Figure 2. Virologic Response Through Week 48, Epv20001ab (intent-to-treat) (166abd26 675e 4832 9d18 0567f2a9d4e4 03)
Epivir 150mg (166abd26 675e 4832 9d18 0567f2a9d4e4 04)
Product ID: PE036706 is a tablet called Epir 150mg. The package contains 900 tablets and the expiry date is not readable. The tablet is manufactured by Cumsnion Andsiri. The text also contains some random characters and numbers and mentions something about RX only and Exp date.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
